Books on the topic 'Late gadolinium magnetic resonance imaging'

To see the other types of publications on this topic, follow the link: Late gadolinium magnetic resonance imaging.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 18 books for your research on the topic 'Late gadolinium magnetic resonance imaging.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

M, Runge Val, ed. Enhanced magnetic resonance imaging. St. Louis: Mosby, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Werner, Krause, and Brücher E, eds. Contrast agents.: Magnetic resonance imaging. Berlin: Springer, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ferrari, Victor. The EACVI Textbook of Cardiovascular Magnetic Resonance. Edited by Massimo Lombardi, Sven Plein, Steffen Petersen, Chiara Bucciarelli-Ducci, Emanuela Valsangiacomo Buechel, and Cristina Basso. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198779735.001.0001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Cardiovascular magnetic resonance imaging (CMR) has become one of the great pillars of cardiac imaging. Modern CMR, as we now practise it, is the result of an enormous method and application development effort that has occurred over the past 25 years and has taken CMR from its humble beginnings of anatomical T1- and T2-weighted imaging to the extremely versatile, accurate, and robust technique it is now. The main developments over this time, building on the anatomical imaging, were the establishment of cine imaging for assessment of cardiac function, first-pass perfusion imaging for measurement of perfusion reserve, as well as myocardial blood flow (in millilitres per minute and gram), late gadolinium enhancement for imaging of scar and patchy fibrosis, and two-dimensional flow velocity imaging for assessment of valve and shunt lesions. This textbook intends to explore and evaluate all areas of this fascinating subject.
4

Glockner, James F., Kazuhiro Kitajima, and Akira Kawashima. Magnetic resonance imaging. Edited by Christopher G. Winearls. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0015_update_001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Magnetic resonance imaging (MRI) provides excellent anatomic detail and soft tissue contrast for the evaluation of patients with renal disease. MRI needs longer scan time than computed tomography (CT); however, no radiation is involved. Gadolinium-based contrast agents (GBCAs) are used to help provide additional image contrast during MRI. MRI is indicated for characterization of renal mass, staging of malignant renal neoplasms, and determination of vena cava involvement by the renal tumour. Magnetic resonance (MR) angiography is widely accepted as a non-invasive imaging work-up of renal artery stenosis. MR urography is an alternative to CT urography to assess the upper urinary tract but does not identify urinary calculi. Diffusion-weighted imaging is a functional MR technique being used to characterize parenchymal renal disease and renal tumours. Nephrogenic systemic fibrosis is a rare but debilitating and potentially life-threatening condition which has been linked to exposure of GBCAs in patients with severe renal insufficiency. The risk versus benefit must be assessed before proceeding.
5

Krause, Werner. Contrast Agents I: Magnetic Resonance Imaging. Springer London, Limited, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Krause, Werner. Contrast Agents I: Magnetic Resonance Imaging. Springer Berlin / Heidelberg, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Krause, Werner. Contrast Agents I: Magnetic Resonance Imaging (Topics in Current Chemistry). Springer, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vymazal, Josef. Cardiovascular MRI: Angiography and Perfusion Studies with I molar Gadolinium-Based Contrast Agent. Informa Healthcare, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Thompson, Caden C. Gadolinium: Compounds, Production and Applications. Nova Science Publishers, Incorporated, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Seligman, Neil S., and Mitchell Chess. Fetal Imaging for the Neurologist. Edited by Emma Ciafaloni, Cheryl Bushnell, and Loralei L. Thornburg. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190667351.003.0005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
In general, ultrasonography and magnetic resonance imaging (MRI) are not associated with maternal or fetal risks and are the imaging techniques of choice for the pregnant patient. Ultrasound is the mainstay of obstetric imaging because it is safe and easily performed. However, MRI is becoming more useful as an adjunct in cases of questionable ultrasound findings or if additional information is needed to plan patient care. MRI lacks the potential risks of ionizing radiation associated with other forms of imaging and, when needed, gadolinium can be used (however, use remains uncommon in current practice). For maternal evaluation in patients with neuromuscular disorders MRI is ideal for imaging. Nevertheless, any imaging (either maternal or fetal) should be used only when needed. Furthermore, if other imaging modalities (CT, MRI with contrast, etc.) are better for assessing the mother’s or fetus’s condition and the information will influence the pregnancy care, these should be utilized.
11

Gruenewald, Simon, and Philip Vladica. Renal transplant imaging. Edited by Jeremy R. Chapman. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
The purpose of imaging of the transplant kidney is to assess integrity, anatomy, and function. Relatively or actually non-invasive technologies can be used to monitor for potential early post-transplant complications such as acute tubular necrosis, acute rejection, haematoma, pyelonephritis, abscess, urinoma, ureteral obstruction, vascular complications, and rarely graft torsion. The technologies also assist in the diagnosis and management of late complications such as those arising from immunosuppression, chronic rejection, lymphocoele, cyst, renal artery stenosis, urinary obstruction, and tumours. This chapter demonstrates the capacity of the various imaging modalities such as ultrasound, computed tomography, and magnetic resonance imaging, to assist in the clinical management of the renal transplant recipient.
12

Lovett, Alexandra, and Whitney W. Woodmansee. A Young Woman with Infertility. Edited by Angela O’Neal. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190609917.003.0010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Prolactinomas are pituitary adenomas that are prolactin-secreting and can lead to galactorrhea, amenorrhea, and infertility. These symptoms often cause women to present earlier than their male counterparts, who are more likely to develop headaches and visual field deficits. Hyperprolactinemia warrants a thorough workup, which should include pregnancy testing, a thyroid-stimulating hormone level, and a thorough review of the patient’s medications. A pituitary-protocoled magnetic resonance image (MRI) with gadolinium should then be performed to look for an adenoma. Prolactinomas can be watched with surveillance levels and imaging or treated with dopaminergic agonists. Treatment resistance is uncommon, though if it occurs, transsphenoidal resection and/or radiation therapy can be considered.
13

Newell-Price, John, Alia Munir, and Miguel Debono. Diagnosis and investigation in endocrine disorders. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0183.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
This chapter introduces the reader to some of the common investigations used in the diagnosis of endocrine disorders. Tests used to diagnose disorders of the thyroid, pituitary, and adrenal glands are discussed. Measurement of plasma levels of thyroid-stimulating hormone, free thyroxine, and free triiodothyronine define the thyroid status. Imaging of the thyroid is usually done in the first instance by ultrasonography. The investigation of pituitary disorders involves measurement of the levels of the multiple pituitary hormones, with basal and dynamic tests as appropriate to the clinical problem. Imaging of the pituitary is typically done using magnetic resonance with gadolinium enhancement. Adrenal disorders (which include hyperaldosteronism, Cushing’s syndrome, and adrenal insufficiency) can be investigated with a range of basal and dynamic tests.
14

Argote-Romero, Graciela. Wilms Tumor. Edited by Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi, and Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Wilms tumor, known as well as nephroblastoma, is the most common primary malignant renal tumor in children. Over 95% of all renal tumors in patients under the age of 15 are Wilms tumors. The mean age at the time of diagnosis is 3.5 years. Wilms tumors are usually an incidental finding, a large abdominal mass discovered by a family member or pediatrician. Hematuria and hypertension can be present at the time of initial diagnosis. Up to 8% of the patients will have von Willebrand disease; therefore, all patients should have baseline coagulation studies. All patients should have either computed tomography of the abdomen and pelvis with oral and intravenous contrast or magnetic resonance imaging of the abdomen and pelvis with gadolinium. Treatment includes radical nephrectomy, chemotherapy, and, in some cases, radiotherapy. Emergency surgery is rarely. The disease-free survival rate is 86% for favorable-histology tumors and 64% for anaplastic tumors.
15

Noutsias, Michel, and Bernhard Maisch. Myocarditis and pericarditis. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Transition of acute myocarditis to dilated cardiomyopathy occurs in approximately 20% of patients within a follow-up period of 33 months. Recent research has revealed the adverse prognostic impact of several clinical parameters for this scenario. Acute myocarditis and its sequelae dilated cardiomyopathy and inflammatory cardiomyopathy are often caused by viral infections. Histological evaluation of endomyocardial biopsies is critical for the diagnosis of the cardiomyopathy entity and for the clinical management of around 20% of the patients. Additionally, contemporary diagnostic procedures of endomyocardial biopsies are indispensable for the selection of inflammatory cardiomyopathy patients who will likely benefit from immunosuppression or antiviral (interferon) treatment. Immunoadsorption, with subsequent immunoglobulin substitution, is a further promising immunomodulatory treatment option for dilated cardiomyopathy patients, targeting primarily the anticardiac autoantibodies. Cardiac magnetic resonance has emerged as a valuable diagnostic approach for myocarditis and pericarditis. Myocardial late gadolinium enhancement has been associated with adverse outcome and sudden cardiac death. Bridging of the first 3–6 months with a wearable cardioverter–defibrillator, until a definitive decision on the implantation of an implantable cardioverter–defibrillator, is a growingly recognized cornerstone in the clinical management of patients with acute myocarditis with depressed left ventricular ejection fraction of <40% and new-onset dilated cardiomyopathy, respectively. Acute pericarditis is labelled idiopathic or suspected viral without adequate proof of the respective aetiology. Non-steroidal anti-inflammatory drugs and colchicine are proven and safe therapeutic mainstays for pericarditis, including the first attack. Pericardiocentesis is a lifesaving treatment of cardiac tamponade. Pericardioscopy and epicardial biopsies can contribute to the aetiological differentiation of pericardial effusions.
16

Noutsias, Michel, and Bernhard Maisch. Myocarditis and pericarditis. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199687039.003.0058_update_001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Transition of acute myocarditis to dilated cardiomyopathy occurs in approximately 20% of patients within a follow-up period of 33 months. Recent research has revealed the adverse prognostic impact of several clinical parameters for this scenario. Acute myocarditis and its sequelae dilated cardiomyopathy and inflammatory cardiomyopathy are often caused by viral infections. Histological evaluation of endomyocardial biopsies is critical for the diagnosis of the cardiomyopathy entity and for the clinical management of around 20% of the patients. Additionally, contemporary diagnostic procedures of endomyocardial biopsies are indispensable for the selection of inflammatory cardiomyopathy patients who will likely benefit from immunosuppression or antiviral (interferon) treatment. Immunoadsorption, with subsequent immunoglobulin substitution, is a further promising immunomodulatory treatment option for dilated cardiomyopathy patients, targeting primarily the anticardiac autoantibodies. Cardiac magnetic resonance has emerged as a valuable diagnostic approach for myocarditis and pericarditis. Myocardial late gadolinium enhancement has been associated with adverse outcome and sudden cardiac death. Bridging of the first 3 months with a wearable cardioverter–defibrillator, until a definitive decision on the implantation of an implantable cardioverter–defibrillator, is a growingly recognized cornerstone in the clinical management of patients with acute myocarditis with depressed left ventricular ejection fraction of <40% and new-onset dilated cardiomyopathy, respectively. Acute pericarditis is labelled idiopathic or suspected viral without adequate proof of the respective aetiology. Non-steroidal anti-inflammatory drugs and colchicine are proven and safe therapeutic mainstays for pericarditis, including the first attack. Pericardiocentesis is a lifesaving treatment of cardiac tamponade. Pericardioscopy and epicardial biopsies can contribute to the aetiological differentiation of pericardial effusions.
17

Schmidt, Dieter, and Simon Shorvon. Resecting Epilepsy. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198725909.003.0005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
The evolution of surgery for epilepsy in the late nineteenth century was partly the consequence of new ideas about the localisation of function in the brain and advances in the understanding of the physiological nature of epilepsy. This was an exciting time of discovery, and really fundamental and novel principles were enunciated which have stood the test of time. New techniques of investigation, including electroencephalography or magnetic resonance imaging, have since led to more accurate ‘targeting’, allowing the elucidation of the anatomical underpinning of epilepsy to be based, not only on semiology as in the earlier years, but also on more objective structural and functional measures. However, the fact remains that most surgery is based on the concept that resecting ‘bad’ tissue, and thus removing the ‘focus’ of epilepsy, will cure the condition—a postulation which has not changed since the time of Jackson (and which has its roots in earlier superstition). Such theories of epilepsy are surely gross simplifications, and the absence of any subsequent paradigm shift is why surgery has really not advanced conceptually much in the last 50 years. Technique and technology have profoundly changed, but the theoretical basis, generally speaking, has not.
18

Thuny, Franck, and Didier Raoult. Pathophysiology and causes of endocarditis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
Abstract:
Endocarditis is defined as an inflammation of the endocardial surface of the heart. This may include heart valves, mural endocardium or the endocardium that covers implanted material, such as prosthetic valves, pacemaker/defibrillator leads and catheters. Infective and non-infective-related causes must be distinguished. In most cases, the inflammation is related to a bacterial or fungal infection with oral streptococci, group D streptococci, staphylococci and enterococci accounting for 85% of episodes. Infective endocarditis (IE) is a serious disease with an incidence ranging from 30 to 100 episodes/million patient-years. From various portals of entry (e.g. oral, digestive, cutaneous) and a subsequent bacteraemia, pathogens can adhere and colonize intracardiac foreign material or onto previously damaged endocardium due to numerous complex processes based on a unique host–pathogen interaction. Rarely, endocarditis can be related to non-infective causes, such as immunological or neoplastic. Mortality is high, with more than one-third dying within a year of diagnosis from complications such as acute heart failure or emboli. This disease still remains a diagnostic challenge with many cases being identified and subsequently treated too late. Diagnosis of IE usually relies on the association between an infectious syndrome and recent endocardial involvement. Blood cultures and echocardiography are the main diagnostic procedures, but are negative in almost 30% of cases, requiring the use of more sophisticated techniques. Computed tomography, magnetic resonance imaging and positron emission tomography are promising imaging modalities. Improved understanding of its pathophysiology and the development of relevant diagnostic strategies enables accelerated identification and treatment, and thus an improved prognosis.

To the bibliography